Lipid-lowering agents (artovastatin)    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
50Dermatomyositis1

50. Dermatomyositis    [ 157 clinical trials,   207 drugs,   (DrugBank: 76 drugs),   47 drug target genes,   142 drug target pathways]
Searched query = "Dermatomyositis", "Polymyositis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 157 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03092154
(ClinicalTrials.gov)
January 20179/3/2017Lipid-lowering Agents in Patients With Dermatomyositis and PolymyositisLipid-lowering Agents in Patients With Dermatomyositis and PolymyositisTreatment Side EffectsDrug: Lipid-lowering agents (Artovastatin)University of Sao PauloNULLRecruiting18 YearsN/AAll40N/ABrazil